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Summary
Cardiac steroids inhibit Na,K-ATPase and the related non-gastric H,K-ATPase, while they do not
interact with gastric H,K-ATPase. Introducing an arginine, the residue present in the gastric H,K-
ATPase, in the second extracellular loop at the corresponding position 334 in the human non-gastric
H,K-ATPase (D334R mutation) rendered it completely resistant to 2 mM ouabain. The corresponding
mutation (E319R) in α1 Na,K-ATPase produced a ~2 fold increase of the ouabain IC50 in the ouabain-
resistant rat α1 Na,K-ATPase and a large decrease of the ouabain affinity of human α1 Na,K-ATPase,
on the other hand this mutation had no effect on the affinity for the aglycone ouabagenin. These
results provide a strong support for the orientation of ouabain in its biding site with its sugar moiety
interacting directly with the second extracellular loop.
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Introduction
According to the classification proposed by Axselsen & Palmgren [1], the group IIc of P-type
ATPases, contains three types of ion motive ATPases composed of an α and a β subunit.
Included in this group are the four isoforms (α1, α2, α3 and α4) of the α subunit of Na,K-
ATPase, the α subunit of gastric proton pump or H,K-ATPase (αHKg) and the α subunit of the
third member of this group, the non-gastric H,K-ATPase (αHKng, initially named ATP1AL1
in human), colonic H,K-ATPase in rat or H,K-ATPase α2 subunit, the product of the ATP12A
gene. This protein is named H,K-ATPase even if its precise ion specificity and transport
stoichiometry are not yet exactly known. All these proteins share highly related sequences with
more than 60% amino acid identity.
The α subunit of the non gastric H,K-ATPase assembles physiologically with the β1 subunit
of Na,K-ATPase [2] although functional expression can be obtained with other β isoforms
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[3]. In this work we have used the β subunit of the rabbit gastric H,K-ATPase with which we
obtain good functional expression of the non gastric H,K-ATPase in Xenopus oocytes.
All Na,K-ATPase α isoforms and αHKng can be inhibited by ouabain (and a group of related
compounds known as cardiac steroids), although with a wide range of sensitivity ranging from
nanomolar for highly sensitive isoforms (Na,K-ATPase α2, α3, and α1 in most species), to
micromolar for moderately sensitive (Na,K-ATPase α4) and submilimolar for poorly sensitive
isoforms (Na,K-ATPase α1 of rodents, Na,K-ATPase α1 of the toad Bufo marinus, and the
non-gastric H,K-ATPases). In contrast, the gastric H,K-ATPase is insensitive to ouabain.
Resistance to ouabain in rodents and Bufo marinus α1 isoform is known to be related to the
presence of charged residues in the first extracellular loop [4] while the low sensitivity of human
and other nongastric H,K-ATPase or the total resistance of gastric H,K-ATPase must be due
to other primary structure differences as these proteins do not have charged residues at
homologous locations.
Cardiac steroids are used for more than 200 years to treat congestive heart failure and are known
for 50 years to be specific inhibitors of Na,K-ATPase. Understanding their binding site and
mechanisms is important first because of their wide clinical use but also because of the presence
of endogenous related compound(s) that may act as hormonal agents to control the activity of
Na,K-ATPase and be implicated in the pathogenesis of conditions such as arterial hypertension
or heart failure [5–7]. Another point of interest is the potential role of cardiac steroids as
signaling molecules and the signal transducer role of Na,K-ATPase [8], and the potential anti-
tumor activity of analogues of cardiac steroids [9;10]. High affinity binding of ouabain to Na,K-
ATPase has been studied in details and major progress have been made recently by determining
several residues directly involved in the structure of the ouabain binding site by the study of
mutants in which residues belonging to the gastric and non gastric H,K-ATPases were
exchanged with those of a sensitive form of Na,K-ATPase [11;12]. Besides the well known
role of charged residues in the first extracellular loop [13], a small number of residues in the
second (transmembrane segments M3-M4) and third (M5-M6) hairpin were shown to be
essential for high affinity binding. A structural model of ouabain in its binding site was
proposed in which several of these residues make H-bonds with ouabain [11;12]. Several
aspects of this model remain hypothetical and some residues that are functionally important
are not predicted to make direct contact with the ouabain molecule. Thus more experimental
data are needed to obtain a complete and safe model of the ouabain binding site.
To better understand the mechanism of ouabain binding, in particular to the human non gastric
H,K-ATPase, we have selected a number of residues, located on the extracytoplasmic surface
or in the transmembrane segments, which are divergent between Na,K-ATPase and non-gastric
or gastric H,K-ATPase (see table 1), and studied ouabain inhibition of ion transport functions
in wild type and mutant αHKng and α1 Na,K-ATPase proteins in which residues were
exchanged.
Materials and Methods
Mutant constructions
Five mutants of human αHKng were created in which a residue was replaced by the amino
acid present at the homologous position in the sequence of rat α1 (K329E, L942E) or α2 or α3
(K329G), in both Na,K- or gastric H,K-ATPase (A800P) or in the gastric H,K-ATPase
(D334R). Similarly, 4 mutants of rat Na,K-ATPase α1 were created in which a residue was
replaced by the amino acid present at the homologous position in the sequence of human
αHKng (E314K, P785A, and V927E) or in gastric H,K-ATPase (E319R). Finally a mutant of
the human α1 Na,K-ATPase (E319R) was created in the same way (table1).
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Mutagenesis was performed using Quickchange II XL site-Directed Mutagenesis Kit
(Stratagene), following the manufacturer’s instructions . All mutations were confirmed by
sequencing. cRNA of α and β subunits was prepared by in vitro transcription.
Expression in Xenopus oocytes
Xenopus laevis were anaesthetized by immersion in MS 222 (2 g/l; Sandoz, Basel, Switzerland)
and ovarian tissue was removed. Frogs were killed by decapitation under MS 222 anesthesia.
Stage V/VI oocytes were collected from the ovarian fragments treated with collagenase as
described earlier [14]. cRNA of mutant and wild type α subunit (8–10 ng) and β subunit (1 ng)
was injected into the vegetal pole of the oocytes. The rat β1 subunit was expressed with the rat
α1 subunit and rabbit βHK was expressed with the human αHKng. Two to 3 days later the
oocytes were loaded with Na+ by exposure to a K+-free solution containing 0.2 μM ouabain
in order to inhibit the oocyte endogenous Na,K-ATPase. This concentration of ouabain inhibits
more than 95% of the endogenous oocyte Na,K-ATPase while it has practically no effect on
resistant isoforms such as rat α1 Na,K-ATPase or non gastric H,K-ATPase [3;15;16].
Electrophysiological measurements
The functional expression of wild type and mutant Na,K-ATPase was first studied by the 2-
electrode voltage clamp technique starting in the following control K+ free solution : (in mM)
Na+ 87.4, Ca++ 0.4, Mg++ 0.8, N-methyl-D-glucamine (NMDG) 5, Cl− 86.0, HCO3− 2.4, 4-
(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES) 10.0. The current induced by
addition of 10 mM K+ (IK+) was recorded as well as the current inhibited by 2 mM ouabain
added to the solution containing 10 mM K+ solution.
For the measurements of ouabain inhibition constant (KI) in oocytes expressing rat α1/β1 Na,K-
ATPase or human αHKng/rabbit βHK , the current was recorded in the 10 mM K+ solution
and then during exposure to increasing concentrations of ouabain (50, 200, 600 μM and 2.0
mM).
For measurements of ouabain KI in human α1β1 Na,K-ATPase which has a much higher
affinity for ouabain (close to that of the Xenopus oocyte Na,K-ATPase) it was not possible to
inhibit the endogenous component by exposure to low doses of ouabain. and also, because of
the slow association rate constant of ouabain, it was not possible to use acute exposure to
increasing concentration of ouabain. We therefore started with Na+ loaded oocyte injected
either with the human β1 alone or wild type or mutant α1 + β1 human Na,K-ATPase. We then
exposed groups of oocytes to various concentrations of ouabain during 1 hour to reach
equilibrium binding and then measured rapidly (within 1 min) the current induced by 10 mM
K+ and then the current inhibited by a high concentration (2 mM) of ouabain. This concentration
is expected to inhibit very close to 100 % of the sensitive human α1β1 Na,K-ATPase. Ouabain
KI was obtained by analyzing the relationship between the remaining ouabain-sensitive current
and the concentration of ouabain during the 1 h exposure. To obtain the affinity of the
exogenous component the mean current measured in the oocytes expressing the β subunit alone
(endogenous component) was subtracted at each corresponding ouabain concentration.
86Rb uptake measurements
86Rb uptake was performed as previously described [17]. In brief, oocytes were injected either
with 8 ng ATP1AL1 cRNA or with 8 ng rat Na,K-ATPase α1 subunit cRNA in combination
with 1 ng of the β subunit of the rabbit gastric H,K-ATPase (βHK) or 1 ng rat β1 cRNA,
respectively. After loading of the oocytes with Na+ (see above) and recovery in a solution
containing 90 mM NaCl, 2 mM CaCl2, 5 mM BaCl2, 10 mM MOPS, pH 7.4, and 0.2 μM
ouabain to inhibit the endogenous oocyte Na,K-ATPase, oocytes were transferred to a solution
containing 5 mM KCl, 90 mM NaCl, 1 mM CaCl2, 5 mM BaCl2, 1 mM MgCl2, 10 mM Hepes,
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pH 7.4, containing 10 μM bumetanide. After addition of 5 μCi/ml 86Rb (Amersham), oocytes
were incubated for 12 min at room temperature with or without ouabain, before washing in a
solution containing 90 mM NaCl, 1.0 mM CaCl2, 1.0 mM MgCl2 and 10 mM Hepes, pH 7.4.
Individual oocytes were dissolved in 0.5% SDS and counted.
Results
Inhibition by ouabain of human αHKng mutants
86Rb uptake was measured in wild type rat α1β1 Na,K-ATPase and in wild type and mutant
human αHKng coexpressed with the β subunit of the rabbit gastric H,K-ATPase (βHK), in the
absence and in the presence of ouabain. In all cases, the endogenous Na,K-ATPase was
inhibited by previous exposure to 0.2 μM ouabain. As shown in figure 1, wild type ATPases
and all mutants were well expressed with a robust 86Rb uptake after subtraction of the uptake
observed in the oocytes expressing only the β subunit. Two αHKng mutants (K329E and
D334R) showed a slightly reduced transport function to about 60% of the wild type αHKng.
Ouabain, at a 2 mM concentration, inhibited more than 80% of the 86Rb uptake in wild type
rat α1β1 Na,K-ATPase and αHKng/βHK, a value compatible with published values of ouabain
inhibition constant (KI) for these enzymes. All the mutants were inhibited to a similar extend
by 2 mM ouabain, except D334R for which there was no significant difference between the
conditions with and without ouabain. This result indicate a very high level of resistance to
ouabain inhibition, similar to that observed in the gastric H,K-ATPase. Because of the difficulty
to solubilize ouabain at concentration much higher than 2 mM it would not be possible to obtain
direct KI measurement with this mutant.
Inhibition by ouabain of Na,K-ATPase mutants
The current activated by addition of 10 mM K+ to a previously K+-free solution (IK) and the
current inhibited by 2 mM ouabain (Iouab) added in the presence of 10 mM K+ were measured
in the wild type and mutant Na,K-ATPase. All the mutants had a good electrogenic functional
expression but 2 of them (E319R and V927E) had a significantly reduced expression to about
50% and 70% of wild type, respectively. In all cases the current inhibited by 2 mM ouabain
was similar to the current activated by K+, indicating that no major change of ouabain affinity
had occurred.
To assess more precisely the affinity for ouabain, the effect of progressively higher
concentrations of ouabain (0, 0.5, 0.2, 0.6 and 2 mM) were applied in the presence of 10 mM
K+ resulting in the inhibition curves shown in figure 2. Ouabain KI values were similar in the
wild type Na,K-ATPase and in the E314K and V927E mutants, 153, 173 and 157 μM,
respectively, while the apparent affinity for ouabain was decreased about two-fold (KI 328
μM) for the E319R mutant, and increased about two-fold (KI 75 μM) for the P785A mutant.
Inhibition of the E319R mutant of the human Na,K-ATPase α subunit by ouabain and
ouabagenin
The lower affinity of E319R for ouabain is consistent with the results recently reported by Qiu
et al. (2005) who showed that this residue is directly involved in the structure of the ouabain
binding site. These authors propose a structural model in which E319 directly interacts with
the sugar moiety of ouabain through a H-bound. This hypothesis requires that ouabain is
oriented in its binding site with its sugar part between the extracellular part of M4 and that of
the M1–M2 hairpin. To test for a direct link between E319 and the rhamnose part of ouabain,
we compared the inhibition of wild type and E319R mutant Na,K-ATPase by the glycoside
ouabain and its aglycone ouabagenin. Because of resistance to ouabain and the potentially even
lower affinity of the aglycone, we could not define precisely the affinity of ouabagenin for the
rat α1 Na,K-ATPase. We have therefore generated the E319R mutant of the human α1 subunit
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of Na,K-ATPase and performed these studies by measuring steady state inhibition after 1-h
incubation at various concentrations of ouabain or ouabagenin, as described in the Methods
section.
As shown in figure 3, there was a large difference in the apparent affinity between wild type
human α1 Na,K-ATPase and the E319R mutant (P < 0.001), while there was no significant
difference for ouabagenin. These results support the presence of a direct interaction between
E319 and the sugar moiety of ouabain.
Discussion
Major progress have been made recently in the characterization of the high affinity cardiac
steroid binding site present at the extracellular surface of Na,K-ATPase, particularly by the
use of amino acid exchange between Na,K-ATPase and the related gastric or non-gastric H,K-
ATPases [11;12]. The determinants of the low affinity ouabain inhibition of the non-gastric
H,K-ATPase is less well understood and was addressed in the present work.
Qiu et al. [12] have shown that the position of E319 (E312 in their numbering) position is one
of the most important residues for high affinity ouabain binding of Na,K-ATPase. Here we
show that mutating this glutamic acid residue in αHKng to arginine (mutant D334R) renders
the non gastric H,K-ATPase completely resistant to ouabain. Arginine-330 is a highly
conserved residue present in all known gastric H,K-ATPase sequences at the position
homologous to D334 in αHKng. It seems thus likely that this sequence divergence between
gastric and non-gastric H,K-ATPase is crucial to the difference in low affinity ouabain binding
between these two related proteins.
In Na,K-ATPase, the E319R mutant had also a lower apparent affinity for ouabain, an
observation consistent with those recently reported by Qiu et al. (2005) who showed that a
similar mutant had a reduced ouabain binding and proposed that it is directly involved in the
structure of the ouabain binding site and interacts with ouabain through a H-bound. The
difference was however only a two-fold change in the case of Na,K-ATPase compared to a
much larger change for the homologous mutation in αHKng.
Two main orientations of ouabain in its binding site have been proposed. The possibility to
label a cysteine in M1 with the steroid derivative HDMA (in which the reactive group is located
at the position of the sugar of ouabain) suggested that the ouabain was oriented with its sugar
part towards the first hairpin formed by the M1 and M2 transmembrane segments [18]. A more
precise position of ouabain in its binding site has been proposed by Qiu et al. [11;12] who
proposed that E319, a residue located at the extracellular end of M4, directly interacts with the
rhamnose part of ouabain through a H-bound. Other authors [19] have proposed a rather
opposite orientation of ouabain in its binding site with the sugar moiety pointing rather to the
transmembrane segments 9 and 10. Our results show that a mutation of E319 has a large effect
on the affinity for the glycoside ouabain but does not influence the binding of the corresponding
aglycone supporting the hypothesis put forward by Qiu et al. [11;12].
Because P785 of α1 Na,K-ATPase is located close to the cation binding site and rather distant
from the putative ouabain binding site, the small effect of the P785A mutation in rat α1 may
be explained by an allosteric type of effect due to a change in cation affinity or conformational
equilibrium.
In summary, our results confirm the importance of a charged residue in the extracellular part
of the 4th transmembrane segment of α1 Na,K-ATPase and show that this position is also crucial
for the effect of ouabain on the human non-gastric H,K-ATPase. In addition, we provide
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experimental data supporting a direct interaction of the sugar moiety of ouabain with the second
extracellular loop allowing to define the orientation of the ouabain molecule in its binding site.
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Abbreviations
αHKng  
α subunit of the non gastric H,K-ATPase
αHKg  
α subunit of the gastric H,K-ATPase
M4, M5  
4th , 5th transmembrane segments
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Figure 1.
Transport function of wild type and mutant αHKng expressed in Xenopus oocytes. 86Rb uptake
was measured as described in the text after inhibition of the endogenous oocyte Na,K-ATPase
by overnight exposure to 0.2 μM ouabain. White and black columns represent the uptake
observed in the absence and in the presence of 2 mM ouabain, respectively. The number of
measurements is between 18 and 22 in each group.
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Figure 2.
Steady state ouabain concentration/inhibition curves of the K+ activated outward current in
oocytes expressing wild type and mutant rat α1/β1 Na,K-ATPase. Exposure to ouabain was
performed in the presence of 10 mM K+ extracellular concentrations. Solid lines show the best
fitting normalized current (Inorm) curves to the equation
Inorm = 1 − 1/ (1 + KIouabain )
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Figure 3.
Ouabain and ouabagenin inhibition constants (KI) in wild type and E319R mutant α1/β1 human
Na,K-ATPase. The results are the mean of 9 to 11 measurements in each group.
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Table 1
Alignment of human α1 Na,K-ATPase, α non-gastric H,K-ATPase and α gastric H,K-ATPase sequences in the
regions concerned by the mutations. On the right are shown the mutants generated and studied in this work.
[[wild type sequences|]] [[|]] [[mutants|]]
[[== M4 ==|]] [[|]]
α1NaK SLILE314YTWLE319AVIF [[α1NaK|]] E314K E319R
αHKng AVSLK329YQVLD334SIIF [[αHKng|]] K329E K329G D334R
αHKg AMCIG325YTFLR330AMVF [[|]]
[[====== M5 ======|]] [[|]]
α1NaK LTSNIP785EIT788PFLI [[α1NaK|]] P785A
αHKng LTKNIA800ELC803PFLI [[αHKng|]] A800P
αHKg LTKNIP796ELT799PYLI [[|]]
[[===== M8 ======|]] [[|]]
α1NaK AFFVSIV927VVQWAD [[α1NaK|]] V927E
αHKng AFFVGIL942VQQIAD [[αHKng|]] L942E
αHKg VFFISIE938VCQIAD [[|]]
Biochem Biophys Res Commun. Author manuscript; available in PMC 2007 September 20.
